FY2024 Earnings Forecast for U.S. Physical Therapy, Inc. (NYSE:USPH) Issued By Barrington Research

U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) - Investment analysts at Barrington Research cut their FY2024 earnings per share (EPS) estimates for U.S. Physical Therapy in a report issued on Wednesday, October 9th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings per share of $2.20 for the year, down from their prior forecast of $2.30. Barrington Research has a "Outperform" rating and a $108.00 price target on the stock. The consensus estimate for U.S. Physical Therapy's current full-year earnings is $2.51 per share. Barrington Research also issued estimates for U.S. Physical Therapy's Q4 2024 earnings at $0.56 EPS, Q1 2025 earnings at $0.43 EPS, Q2 2025 earnings at $0.77 EPS, Q3 2025 earnings at $0.61 EPS and Q4 2025 earnings at $0.69 EPS.

Several other brokerages have also recently commented on USPH. StockNews.com upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Wednesday, August 21st. Bank of America reiterated a "neutral" rating and set a $90.00 target price (down previously from $114.00) on shares of U.S. Physical Therapy in a research report on Monday.

U.S. Physical Therapy Price Performance

NYSE USPH traded down $0.68 during trading on Thursday, reaching $77.52. 173,524 shares of the company traded hands, compared to its average volume of 88,940. The company has a market cap of $1.17 billion, a price-to-earnings ratio of 62.72, a P/E/G ratio of 3.97 and a beta of 1.39. U.S. Physical Therapy has a 1-year low of $76.18 and a 1-year high of $113.63. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.88 and a current ratio of 1.88. The stock's 50 day moving average price is $84.76 and its two-hundred day moving average price is $94.73.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing analysts' consensus estimates of $0.82 by ($0.09). The company had revenue of $167.19 million for the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The firm's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.76 earnings per share.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of USPH. Northwest Bank & Trust Co bought a new position in U.S. Physical Therapy in the fourth quarter valued at $37,000. Vanguard Group Inc. raised its holdings in U.S. Physical Therapy by 2.5% during the fourth quarter. Vanguard Group Inc. now owns 1,062,427 shares of the company's stock worth $98,954,000 after acquiring an additional 26,224 shares in the last quarter. Bridge City Capital LLC boosted its position in U.S. Physical Therapy by 1.7% during the first quarter. Bridge City Capital LLC now owns 37,198 shares of the company's stock valued at $4,199,000 after purchasing an additional 608 shares during the last quarter. Chatham Capital Group Inc. increased its position in shares of U.S. Physical Therapy by 14.5% during the 1st quarter. Chatham Capital Group Inc. now owns 19,400 shares of the company's stock worth $2,190,000 after purchasing an additional 2,450 shares during the last quarter. Finally, Norden Group LLC raised its stake in shares of U.S. Physical Therapy by 1,841.6% during the 1st quarter. Norden Group LLC now owns 63,938 shares of the company's stock worth $7,217,000 after purchasing an additional 60,645 shares in the last quarter.

Insider Activity

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the business's stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the transaction, the chief operating officer now directly owns 7,038 shares of the company's stock, valued at approximately $580,635. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Kathleen A. Gilmartin bought 2,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Tuesday, September 3rd. The stock was purchased at an average cost of $86.09 per share, with a total value of $172,180.00. Following the purchase, the director now owns 18,904 shares in the company, valued at approximately $1,627,445.36. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the transaction, the chief operating officer now owns 7,038 shares of the company's stock, valued at approximately $580,635. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is owned by company insiders.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Friday, August 23rd were given a dividend of $0.44 per share. The ex-dividend date was Friday, August 23rd. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.27%. U.S. Physical Therapy's dividend payout ratio is 143.09%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.